These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 9586325)
41. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379 [TBL] [Abstract][Full Text] [Related]
42. [Prognostic implication of morphometric stromal parameters of renal pelvis and ureteral transitional cell carcinomas]. Al'-Shukri CKh; Rybakova MG; Makovskaia AI; Tiurin AG; Kozlov VV; Ageev MN; Korneev IA Urologiia; 2004; (3):10-4. PubMed ID: 15199806 [TBL] [Abstract][Full Text] [Related]
43. Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter. Hashimoto H; Sue Y; Saga Y; Tokumitsu M; Yachiku S Int J Urol; 2000 Dec; 7(12):457-63. PubMed ID: 11168685 [TBL] [Abstract][Full Text] [Related]
44. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract. Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504 [TBL] [Abstract][Full Text] [Related]
45. Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma. Jeon HG; Jeong IG; Bae J; Lee JW; Won JK; Paik JH; Kim HH; Lee SE; Lee E Urology; 2010 Aug; 76(2):513.e7-12. PubMed ID: 20573388 [TBL] [Abstract][Full Text] [Related]
46. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169 [TBL] [Abstract][Full Text] [Related]
47. Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. Langner C; Hutterer G; Chromecki T; Leibl S; Rehak P; Zigeuner R J Urol; 2006 Sep; 176(3):910-3; discussion 913-4. PubMed ID: 16890651 [TBL] [Abstract][Full Text] [Related]
48. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727 [TBL] [Abstract][Full Text] [Related]
49. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000. David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030 [TBL] [Abstract][Full Text] [Related]
50. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Jeldres C; Sun M; Lughezzani G; Isbarn H; Shariat SF; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI Cancer; 2010 Aug; 116(16):3774-84. PubMed ID: 20564085 [TBL] [Abstract][Full Text] [Related]
51. [A clinicopathological study on tumor of the renal pelvis and ureter]. Yoneda F; Kan M; Tsujimura H; Nakajima M; Furuya K; Tao S Hinyokika Kiyo; 1989 Oct; 35(10):1665-71. PubMed ID: 2610173 [TBL] [Abstract][Full Text] [Related]
52. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Yang Z; Tang LH; Klimstra DS Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513 [TBL] [Abstract][Full Text] [Related]
53. Primary carcinoma of the renal pelvis and ureter. Evaluation of clinical and pathologic features. Strobel SL; Jasper WS; Gogate SA; Sharma HM Arch Pathol Lab Med; 1984 Sep; 108(9):697-700. PubMed ID: 6547821 [TBL] [Abstract][Full Text] [Related]
54. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007 [TBL] [Abstract][Full Text] [Related]
55. [A clinicopathological study on carcinoma of the renal pelvis and ureter]. Hashimoto H; Saga Y; Tokumitsu M; Yamaguchi S; Morikawa M; Yachiku S Hinyokika Kiyo; 1997 Oct; 43(10):707-12. PubMed ID: 9395905 [TBL] [Abstract][Full Text] [Related]
56. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract. Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597 [TBL] [Abstract][Full Text] [Related]
57. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Stefansson IM; Salvesen HB; Immervoll H; Akslen LA Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995 [TBL] [Abstract][Full Text] [Related]
58. [Prognostic criteria in patients with renal pelvic and ureteral cancers--clinical value of volume weighted mean nuclear volume]. Aoyama T; Fujikawa K; Sasaki M Hinyokika Kiyo; 1996 Nov; 42(11):841-5. PubMed ID: 8973933 [TBL] [Abstract][Full Text] [Related]
59. Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Lehmann J; Suttmann H; Kovac I; Hack M; Kamradt J; Siemer S; Wullich B; Zwergel U; Stöckle M Eur Urol; 2007 May; 51(5):1281-8. PubMed ID: 17125909 [TBL] [Abstract][Full Text] [Related]
60. Micropapillary urothelial carcinoma of the upper urinary tract: Clinicopathologic study of five cases. Perez-Montiel D; Hes O; Michal M; Suster S Am J Clin Pathol; 2006 Jul; 126(1):86-92. PubMed ID: 16753597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]